Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 10.25 +0.23 (2.30%)
Previous Close $10.02    52 Week High
Open $10.12    52 Week Low
Day High $10.27    P/E N/A 
Day Low $9.83    EPS
Volume 22,875,609